LAUSR

OBJECTIVE The aim: To study medical and pharmaceutical specialists' approaches to outpatient injection treatment and their impact on the quality of medical care. PATIENTS AND METHODS Materials and methods: The object of the study was the answers of health care professionals (n=1408) to the questions on the use of injectable pharmacotherapy in personal treatment, listed in a specially designed questionnaire on a single protocol. System analysis, questionnaire survey, statistical, comparative-and-analytical methods were used. RESULTS Results: The quality of outpatient injectable pharmacotherapy, according to the results of a survey of medical and pharmaceutical specialist, can be considered inappropriate, as in 52.9% of respondents the local adverse reaction were significantly more likely to develop compared to the respondents who did not have any local adverse reaction (χ2=21.7819, p<0.05). Most often, the following complications of injectable pharmacotherapy occurred in the analyzed respondents: pain - 45.8%; hardening - 28.3% and reddening - 21.7%. When conducting home-based treatment, 42.8% of the respondents involved persons without medical education for the execution of procedures, which is significantly more frequent (χ2=26.5556, p<0.05) in comparison with the respondents who invited medical personnel (27.0%) and used the method of self-injection (30.2%). CONCLUSION Conclusions: The results of a survey of medical and pharmaceutical specialists revealed that home-based injectable treatment, based mainly on their own experience, is common in the occupational environment of health care professionals.